A Pharmaceopidemiological study in patients who use Symbicort SMART
Study identifier:D5890C00017
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Pharmaceopidemiological study in patients who use Symbicort Turbuhaler as maintenance and reliever therapy (Symbicort SMART) capturing over use and under use via the General Practice Research Database
Medical condition
Bronchial Asthma
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1000
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Jun 2007
Primary Completion Date: 01 May 2010
Study Completion Date: 01 May 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Catriona McMahon
AZ UK MC
